Study identity card

VaQDENV

Italy
Share
  • Disease: Arboviral disease, Vector-borne disease
  • Study type: Observational Cohort Study, Prevention
  • Study type descriptors: Single centre, prospective
  • Objective: To learn about the immunity induced by the Qdenga vaccine
  • Number of participants enrolled: Enrollment ongoing
  • Study enrolling from to
  • Study includes follow-up for 2 months

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Outpatient clinic
  • Arbovirus
  • Dengue virus
  • Vector-borne disease
  • Arboviral disease
  • Vector-borne disease
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • Qdenga

Other information

The information was provided with the aid of the study investigators

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to